6 reports

The diabetes care and obesity segment provides GLP-##, insulin and related delivery systems as well as oral anti-diabetic and obesity drugs.

  • Diabetes
  • Insulin
  • Insulin Delivery
  • Medical Device
  • Ypsomed AG

The diabetes care and obesity segment provides GLP-##, insulin and related delivery systems as well as oral anti-diabetic and obesity drugs.

  • Diabetes
  • Insulin
  • Insulin Delivery
  • Medical Device
  • Ypsomed AG

The revenue of company is from two product offerings, namely, Omnipod and Drug delivery.

  • Diabetes Care
  • Diabetes Monitoring
  • Insulin
  • Becton, Dickinson and Company, Ltd
  • Ypsomed AG

Pens are preferred for drug delivery due to its user-friendliness and ease of use compared to syringes.

  • Injectable Delivery
  • Insulin
  • B. Braun Melsungen AG
  • Novo Nordisk Group
  • Ypsomed AG

Victoza, launched by Novo Nordisk, is the first blockbuster GLP-## drug.

  • Antidiabetics
  • Diabetes Care
  • Insulin
  • Insulin Delivery
  • Ypsomed AG

##.

  • Healthcare
  • Insulin
  • Insulin Delivery
  • Medical Device
  • Ypsomed AG